<DOC>
	<DOCNO>NCT00914199</DOCNO>
	<brief_summary>Should , , perform dilatation side branch main vessel stent , acceptable blood flow side branch ?</brief_summary>
	<brief_title>The Nordic Bifurcation Study III</brief_title>
	<detailed_description>Design : - Randomised open multicentre trial Patients : - Number 477 Randomisation : - Treatment strategy kiss kiss balloon post-dilatation Primary end point : - Combined end point : cardiac death , index lesion myocardial infarction , stent thrombosis target lesion revascularisation 6 month . Secondary end point : - Clinical - MACE ( cardiac death , myocardial infarction , stent thrombosis target vessel revascularisation ) hospital period , 1 , 8 , 14 month , 2 , 3 , 5 year . - Cardiac death hospital period , 1 , 8 14 month , 2 , 3 , 5 year . - Myocardial infarction hospital period , 1 , 8 14 month , 2 , 3 , 5 year . - Stent thrombosis hospital period , 1 , 8 14 month , 2 3 year . - Target vessel revascularisation hospital period , 1 , 8 14 month , 2 3 year . - Total mortality hospital period , 1 , 6 , 8 14 month , 2 3 year . - Target lesion revascularisation hospital period , 1 , 8 14 month , 2 3 year . - Myocardial infarction relate index procedure . - CCS angina score 1 , 8 14 month , 2 , 3 , 5 year . - Angiographic . Angiographic significant stenosis ( &gt; 50 % ) main vessel and/or occlusion side branch 8 month . - Late loss main vessel side branch 8 month . - Angiographic significant stenosis ( &gt; 50 % ) main vessel and/or side branch 8 month . - Angiographic significant stenosis ( &gt; 50 % ) main vessel 8 month . - Angiographic significant stenosis ( &gt; 50 % ) side branch 8 month . - Markers . All patient stable angina pectoris patient unstable angina pectoris , normal marker ( CK-MB TnT/TnI ) procedure , enter marker study . End point evaluation : - Primary secondary end point assess independent end point committee . The end point committee consist experience cardiologist . The detailed end point definition follow : - Q wave myocardial infarction . Appearance new Q wave two contiguous lead ECG . - Non Q wave myocardial infarction.Infarction , consider present patient clinical , angiographic electrocardiographic and/or laboratory evidence myocardial necrosis ECG show new Q wave - Procedure relate myocardial infarction . A &gt; threefold increase CK-MB Troponin-T/I . - Target lesion revascularization . Coronary bypass operation graft PCI index lesion . - Target vessel revascularization . Coronary bypass operation graft PCI index vessel - Stent thrombosis . Stent thromboses categorize acute , sub acute , late late definite , probable possible ( see appendix ) . - Vessel measurement . Proximal reference diameter : Vessel diameter proximal lesion.Distal reference diameter : Vessel diameter distal lesion.Percentual diameter stenosis : ( Reference diameter - minimal luminal diameter ) /reference diameter percent . - Angiographic restenosis . &gt; 50 % diameter stenosis . - Recommendations re-revascularization . Main vessel : Angina pectoris , CCS 1 related index lesion stenosis diameter &gt; 40 % * Stenosis diameter &gt; 70 % * . Side branch : AP , CCS &gt; 1 related index lesion stenosis diameter &gt; 40 % * - The stenosis diameter evaluate eyeball . Angiographic core lab : - The index follow-up angiogram asses QCA-laboratories Department Cardiology , Paul Stradins Clinical Hospital , Riga , Latvia Department Cardiology B , Aarhus University Hospital Skejby , Aarhus N , Denmark . Definition index angiography : - The angiography obtain PCI-procedure use index angiography Follow-up angiography : - After 8 month conventional diagnostic angiography perform projection use index angiography repeat 0.1 mg intracoronary nitroglycerine . The index angiogram store CD send mail angiographic core laboratory . Steering committee : - The steer committee member select basis participation study . All steer committee member full access database participate interpretation data . Progress study : - The progress study check weekly basis steer committee . They receive evaluate data inclusion rate primary end point event rate . Further , steer committee receive evaluate weekly safety data rate stent thrombosis three group . Statistics data management : - The statistical analysis perform UNI-C , Aarhus . - Primary end point . The composite end point two group six month follow-up describe Kaplan-Meier event graph . The event graph two group compare log-rank test . A two-sided test use . A p-value &lt; 0.05 consider significant . - Secondary end point variable . For continuous variable , difference treatment group evaluate Wilcoxon 's rank-sum test . For discrete variable , difference express count percent analyze chi-square Fisher 's exact test . Secondary end point assess 6 8 month . Two- side test use p-value consider indicating significance 0.05 . Safety : - For safety reason , stent thrombosis one month monitor continuously . A stent thrombosis rate &gt; 5 % treatment group necessitate premature termination study . Analysis population : - The result analyze accord intention-to-treat principle , i.e . patient randomize certain group follow assessed irrespectively actual treatment . Protocol violation note responsible centre notify . Sample size calculation : - A total 225 patient include group , total 450 patient . This base following : We expect MACE rate 2 % group dilatation side branch main vessel stent 8 % group without side branch dilatation main vessel stent . With alfa 5 % strength 80 % , 206 patient need group ( two-sided chi square test ) demonstrate difference . By include 225 patient group , possible dropout follow-up count . Randomization procedure : - The patient randomize successful stenting main vessel . There block randomization accord country stratification accord sex , age &gt; 70 year , diabetes , +/- measurement FFR +/- angiographic follow-up . The patient computer randomize 24 hour telephone service . Monitoring study : - The study monitor accord GCP rule independent professional . Publication : - Results , positive well negative , publish international cardiovascular journal . Publication author issue decide steer committee basis general involvement study ( core lab . function , end point committee membership etc . ) number include patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Stable unstable angina pectoris . Bifurcation lesion `` LAD/diagonal '' , `` Cx/obtuse marginal '' , `` RCA PDA/posterola¬te¬ral branch '' `` LM/Cx/LAD '' . Diameter main vessel visual estimate &gt; 2.5 mm . Diameter side branch visual estimate &gt; 2.25 mm . Signed informed consent Age &lt; 18 year . STelevation infarction within 24 hour . Expected survival &lt; 1 year . Screatinine &gt; 200 µmol/l . Allergy Aspirin , Clopidogrel Ticlopidine . Allergy Sirolimus .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PCI</keyword>
	<keyword>Bifurcation lesion</keyword>
</DOC>